SLIDE 1 Interventions for Transition Age Youth with Co‐
- ccurring Mental Health and Substance Use Issues
Sherry Larkins, Ph.D. UCLA Integrated Substance Abuse Programs September 7, 2011
SLIDE 2
Agenda
Review importance of epidemiological data – understand adolescent substance issues. Review substances of abuse and how addictions develop Review standardized screening & assessment infrastructure to support the move to improve treatment effectiveness Review clinical strategies deemed EB as brief treatments/interventions for adolescents with co-occurring MH and SUD
SLIDE 3 The Spectrum of Interventions
Prevention/ Education Formal Specialized Treatments *Brief Treatments Brief Advice *Brief Interventions
3
SLIDE 4 Dennis, 2002
10 20 30 40 50 60 70 80 90 100
12 13 14 15 16 17 18 19 20 21 22-23 24-25 26-29 30-34 35-39 50-64 65 +
Alcohol Use Tobacco Use Binge Alcohol use Any Illicit Drug Use Marijuana Use
Substance Use Disorders are Adolescent Onset Disorders
Research shows that 90% of all adults with dependence started using under the age of 18, half of which were under the age of 15.
SLIDE 5 Where have we been?
Past decade, adolescent substance use field has gained growing attention
Moving away from adult paradigm
Since 1997 research has grown tremendously
Supported the field as an “emerging science”
SLIDE 6 Adolescent Substance Abuse Research Adolescent Substance Abuse Research
Feature 1930-1997 1997-2009
Treatment Studies 16 500+ Random/Quasi 9 48+ Tx Manuals 50+ QA/Adherence Rare Common Practice Epidemiology Studies Slow Common Tracking Evaluations Descriptive/Simple More Advanced Economic Some Cost Cost, CEA, BCA
Growth has helped shape service improvement agendas
SLIDE 7
What does Epidemiology Research Tell Us about Adolescent Substance Use Problems?
SLIDE 8 National Survey Data: Substance Abuse/Dependence among Youth (12-17)
National Survey on Drug Use and Health 20 0 2– 20 0 9
SLIDE 9
Clinical Concern: Whose Presenting for Treatment?
SLIDE 10 National Treatment Data: Adolescent Admissions by Primary Substance of Abuse/Dependence
Treatment Episode Data Set (1996-2006)
SLIDE 11 Com m on Use Trends…
Mainstay Substances
- Tobacco
- Alcohol
- Marijuana
Hot Issues at the National front
- Prescription & over-counter medications
- Inhalants
- Club Drugs (MDMA – “x”)
Where are adolescents at with harder drugs?
- Harder Drugs – meth, cocaine, heroin
Access & Availability
SLIDE 12
Every Generation of Teens Looks for New Ways to Get “High”
SLIDE 13 Substance Use Disorders Onset in Adolescents
Source: Dennis et al 2008 10 20 30 40 50 60 70 80 90 100 12-13 14-15 16-17 18-20 21-29 30-34 35-49 50-64 65+ No Alcohol or Drug Use Light Alcohol Use Only Any Infrequent Drug Use Regular AOD Use Abuse Dependence NSDUH Age Groups Severity Category
Adolescent Onset Remission
SLIDE 14 Progression of Use
FAS---Substance use in-uterus No Social Use Experimentation Use Use Abuse Dependence
- 0-2 3-5 6-8 9-10 11-12 13-14 15-16 17+
Infant Child Pre- Adolescent adolescent Mental Health Disorder’s onset---------------------------------- Use: Isolation with substance-loss of relationships Abuse: DMS IV Dependence: DSM IV
SLIDE 15 Onset of Mental Health Disorders
- Oppositional Defiance 5y/o
- Attention Deficit Disorder-ADHD 1.3-2.4
- Anxiety Disorders 3.8
- Conduct Disorder 5.6
- Depression 10.1
- Schizophrenia-affective disorders
» Teen years and mid-thirties
SLIDE 16
Continuum of Adolescent Substance Use
SLIDE 17 Clinical Risk & System Response
Pre Use Abstinence Substance Dependence Substance Abuse 15% of the Population 15% of the Population
70% of the Population
Experimental Use Social/Recreational Use Misuse Primary Prevention Services Traditional Treatment Secondary Prevention Brief Intervention = Educational Brief Intervention Brief Treatment
Source: SBIRT Project 2007, Stephen O’Neil
Clinical Trajectory
SLIDE 18 18
Review of Psychoactive Drugs
SLIDE 19 19
Classifying psychoactive drugs
Depressants Stimulants Hallucinogens
Alcohol Amphetamines LSD, DMT Benzodiazepines Cocaine Mescaline Opioids Nicotine PCP Solvent/Inhalants MDMA/Ecstasy Ketamine Barbiturates Khat Cannabis (high doses) Cannabis (low doses) Caffeine Mushrooms “Bath Salts” MDMA
SLIDE 20 Why do people initiate drug use? (1)
To Feel Good
Novel Feelings Sensations Experiences AND To share them
To Feel Better
Lessen: Anxiety Worries Fears Depression Hopelessness Withdrawal
SLIDE 21 Why Do People Initiate Drug Use (2) ?
Curiosity Availability Peer Pressure To have fun Gain Energy Lose Weight Reduce Pain
SLIDE 22 22
What is drug addiction?
Drug addiction is a complex illness characterised by compulsive, and at times, uncontrollable drug craving, seeking, and use that persist even in the face of extremely negative consequences.
SLIDE 23 Behavioral Responses How Drugs Work
Loss of control limiting intake
Continued compulsive use despite harmful consequences
Characterized by craving, tolerance, withdrawal
Multiple relapses preceding stable recovery
SLIDE 24 24
Craving
Psychological craving is a strong desire or urge to use drugs. Cravings are most apparent during drug withdrawal.
SLIDE 25 25
Tolerance
Tolerance is a state in which a person no longer responds to a drug as they did before, and a higher dose is required to achieve the same effect.
SLIDE 26 26
Withdrawal
The following symptoms may occur when drug use is reduced or discontinued:
Tremors, chills
Cramps
Emotional problems
Cognitive and attention deficits
Hallucinations
Convulsions
Death
SLIDE 27 27
How Does an Addiction Develop?
SLIDE 28 Classical Conditioning: Addiction
- Over time, drug or alcohol use is paired with cues
such as money, paraphernalia, particular places, people, time of day, emotions
- Through classical conditioning these cues are
paired with pleasurable effects of the drug (“high”).
- Eventually, exposure to cues alone produces
drug or alcohol cravings or urges that are often followed by substance abuse
SLIDE 29 Pathway for Understanding Addictive Effects
- f Drugs on the Brain & Behavior
Reward Pathway
SLIDE 30
SLIDE 31 31
The reward system
Natural rewards
Food
Water
Sex
Nurturing
SLIDE 32 50 50 100 100 150 150 200 200 60 60 120 120 180 180
Time (min) Time (min)
% of Basal DA Output % of Basal DA Output
NAc shell NAc shell
Empty Empty Box Box Feeding Feeding Source: Di Chiara et al. Source: Di Chiara et al.
FOOD FOOD
100 100 150 150 200 200 DA Concentration (% Baseline) DA Concentration (% Baseline)
Mounts Mounts Intromissions Intromissions Ejaculations Ejaculations
15 15 5 5 10 10
Copulation Frequency Copulation Frequency Sample Number Sample Number 1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8 9 9 10 10 11 11 12 12 13 13 14 14 15 15 16 16 17 17 Scr ScrScr Scr Bas BasFemale 1 Present
Female 1 Present
Scr Scr
Female 2 Present Female 2 Present
Scr Scr
Source: Fiorino and Phillips Source: Fiorino and Phillips
SEX SEX
Natural Rewards Elevate Dopamine Levels Natural Rewards Elevate Natural Rewards Elevate Dopamine Levels Dopamine Levels
SLIDE 33 33
Activating the system with drugs
SLIDE 34 Source: Shoblock and Sullivan; Di Chiara and
Effects of Drugs on Dopamine Release Effects of Drugs on Dopamine Release
100 100 200 200 300 300 400 400 Time After Cocaine Time After Cocaine % of Basal Release % of Basal Release DA DA DOPAC DOPAC HVA HVA Accumbens Accumbens
COCAINE COCAINE
100 150 200 250 1 2 3 4hr Time After Ethanol % of Basal Release 0.25 0.5 1 2.5 Accumbens Dose (g/kg ip)
ETHANOL
100 100 150 150 200 200 250 250 1 1 2 2 3 hr 3 hr Time After Nicotine Time After Nicotine % of Basal Release % of Basal Release Accumbens Accumbens Caudate Caudate
NICOTINE NICOTINE
Time After Methamphetamine % Basal Release
METHAMPHETAMINE
1 2 3hr 1500 1000 500 Accumbens
SLIDE 35
Prolonged Drug Use Changes the Brain In Fundamental and Long-Lasting Ways
SLIDE 36 BRAIN CHANGES appear prominently in PET scans of current and past drug users Drug users have far less dopamine activity (right), as is indicated by the depletion (dark red shows disruption), compared to the controls (left) Studies show that this difference contributes to dependence and a diseased brain
SLIDE 37 Control > MA
4 3 2 1
SLIDE 38 MA > Control
5 4 2 1 3
SLIDE 39
Clinical Situation is Complicated
Problem Severity
SLIDE 40 Clinical Risk & System Response
Pre Use Abstinence Substance Dependence Substance Abuse 15% of the Population 15% of the Population
70% of the Population
Experimental Use Social/Recreational Use Misuse Primary Prevention Services Traditional Treatment Secondary Prevention Brief Intervention = Educational Brief Intervention Brief Treatment
Source: SBIRT Project 2007, Stephen O’Neil
Clinical Trajectory
SLIDE 41 Complexities for Clinical Tx
Majority of adolescents presenting for tx with more than just substance use problems…
Psychological co-occurring (trauma, depression, anxiety, etc.) histories Delinquent/legal court/probation issues School drop-out/academic failure issues Family dysfunction
SLIDE 42
Clinical Risk Differs Clinical Risk Differs
SLIDE 43 Understanding Problem Severity
Screening is essential To determine RISK - the actual problem severity– where are they along the clinical risk continuum of use? Standardized Screeners
CRAFFT: Eng/Span
Knight et al. 2002
SLIDE 44
Client Screening Activity
SLIDE 45 Responsibility element Coping element – use moves beyond pleasure Isolation/Social Withdraw element Impairment element Problem Use recognized by others Consequences of use*
SLIDE 46 Interviewing for interconnected problems
Medical S u b s t a n c e U s e M e n t a l H e a l t h
46
SLIDE 47
Children’s Forms – Being Revised?
SLIDE 48 Los Angeles DMH Assessment
SUD Mental Health
48
SLIDE 49 Los Angeles DMH Assessment
Mental Health Considerations
Depression Anxiety Anhedonia Psychotic Thinking Trauma/PTSD Confusion Memory Issues …
Medical Considerations
Cirrhosis Gastroenteritis Abscess Diabetes High Blood Pressure HIV/HCV Cardiac Problems TB …
49
SLIDE 50
SLIDE 51 The Spectrum of Interventions
Prevention/ Education Formal Specialized Treatments *Brief Treatments Brief Advice *Brief Interventions
51
SLIDE 52
Continuum of Adolescent Substance Use
SLIDE 53
Turn Our Attention to: Treatment Effectiveness Studies
Tell us about the effectiveness of different treatment models for adolescents with substance use disorders Includes studies with programs deemed “evidence-based” Proven to be successful through research methodology and have produced a consistent pattern of positive results.
SLIDE 54 EBP Brief Treatment Series
Cannabis Youth Treatment Trials
CYT
- 1. Motivational Enhance Treatment/Cognitive
Behavior Therapy (MET/CBT5)
- 2. Cognitive Behavior Therapy 7 (CBT7)
- 3. Family Support Network (FSN)
- 4. Adolescent Community Reinforcement
Approach (ACRA)
- 5. Multidimensional Family Therapy (MDFT)
Treatment Series
SLIDE 55 P e e r S a d n e s s
Negative Emotions
SUD
Family
Physical Problem
Negative Emotions
Mental Health
SUD
SLIDE 56
Difficult Clients are Categorized as…
Main problem: AOD/SUD contributes to their MH issues The client perception of the issue: XXX B/C Disconnect & Mismatch Resistance Distrust Poor Insight/Awareness Low motivation
SLIDE 57 5 Manualized Tx Protocols
Treatment manuals available from National Clearinghouse for Alcohol and Drug Information (NCADI) or www.chestnut.org/li
SLIDE 58 Motivational Enhanced Treatment/ Cognitive Behavior Therapy 5 (MET/CBT5)
Cannabis Youth Treatment Trials
CYT
Treatment Series Volume 1
Sampl, S., & Kadden, R. (2001)
University of Connecticut Health Center Farmington, CT USA
SLIDE 59 Individual MET (MI) Sessions 1 & 2
(50-75 min)
- 1. Assessment Feedback (Review PFR), Rapport-
Building, Orientation to Treatment
- 2. Review of Progress, Functional Analysis,
Personalized Goal Setting, and Orientation to the Group Sessions
SLIDE 60 Group CBT Sessions 1-3
(50-75 Min)
- 1. Drug/ETOH Refusal Skills
- 2. Increasing Social Support
and Pleasant Activities
- 3. Coping with Emergencies
and Relapse Client Preparedness
Plus 2 Random Urines over six weeks
SLIDE 61 Cognitive Behavior Therapy 7 Supplement (CBT-7)
Cannabis Youth Treatment Trials
CYT
Treatment Series Volume 2
Webb, C., Scudder, M., Kaminer, Y., Kadden, R., & Tawfik, Z. (2002)
University of Connecticut Health Center Farmington, CT USA
SLIDE 62 7 Supplemental CBT Sessions:
- 6. Problem-Solving Skills
- 7. Anger Awareness
- 8. Anger Management
- 9. Communication Skills: Assertiveness and Criticism
- 10. Coping with Cravings
- 11. Managing Negative Moods
- 12. Managing Thoughts about Using
SLIDE 63 Stages of Change
Prochaska & DiClemente
SLIDE 64 How you talk to the adolescent matters
You are singing off key if you find yourself…
- Challenging
- Warning
- Finger-wagging
- Moralizing
- Giving unwanted
advice
- Shaming
- Labeling
- Confronting
- Being Sarcastic
- Playing expert
SLIDE 65 Five Strategies of MET
- 1. Express Empathy
- 2. Develop Discrepancy
- 3. Avoid Argumentation
- 4. Roll with Resistance
- 5. Support Self-Efficacy
SLIDE 66
Facilitating the Risk/Reward Analysis
What to focus on: Decisional balance scale
Elicit pros and cons of use and change Emphasize client choice and responsibility
Elicit self-motivational statements, and summarize them (they are hearing what they just said)
SLIDE 67
How do you avoid argumentation with a teenager?
Resistance should be a CUE to modify your approach Treat ambivalence (mixed feelings) as normal
Bring the focus back on their concerns:
Elicit the client’s perceptions of the problem and providing feedback
SLIDE 68
Video Demo:
Goal Setting (MET) & Increasing Social Support/Pleasant Activities (CBT) & Coping with Emergencies
SLIDE 69 Family Support Network (FSN)
Cannabis Youth Treatment Trials
CYT
Treatment Series Volume 3
Hamilton, N., Brantley, L., Tims, F., Angelovich, N., & McDougall, B. (2001). Operation PAR
SLIDE 70 I mportance of the Family! I mportance of the Family!
Substance Use Correlations
Intraclass Correlations w
3-month 6-month 9-month 12- month 95% C.I. Family conflict .56 .48 .47 .43 .58 (.53, .62) Family cohesion .56 .50 .46 .50 .54 (.50, .59) Social support .42 .38 .45 .44 . 50 (.45, .54) Recovery environment risk .42 .42 .37 .24 .43 (.39, .48) Social risk .28 .34 .24 .21 .37 (.32, .42) Substance use .36 .30 .19 .27 .50 (.45, .54) Substance-related problems .43 .35 .31 .31 .46 (.42, .51)
SLIDE 71
A Closer Look at the Family Issue…
Family Support: less family conflict and greater family cohesion corresponded to reduced risk for poor treatment outcomes Although families play a pivotal role, they vary in their ability and willingness to help…
SLIDE 72
How do you facilitate Parental Attendance?
SLIDE 73 Adolescent Community Reinforcement Approach (ACRA)
Cannabis Youth Treatment Trials
CYT
Treatment Series Volume 4
Godley, S. H., Meyers*, R. J., Smith*, J. E., Godley, M. D., Titus, J. M., Karvinen, T., Dent, G., Passetti, L., & Kelberg, P. (2001). Chestnut Health Systems Bloomington, IL USA, and *University of New Mexico Albuquerque, NM USA
SLIDE 74 Multidimensional Family Therapy (MDFT)
Cannabis Youth Treatment Trials
CYT
Treatment Series Volume 5
Liddle, H. A. (2002). University of Miami Miami, FL USA
SLIDE 75
2010 Meta-Analysis
Study of studies conducted to identify treatment effectiveness of various EBP treatment approaches that maximize treatment outcomes (JMATE presentation)
48 studies that included 79 treatment approaches for adolescents
SLIDE 76 Treatment Approaches
Family therapy (k = 25, n = 88) Individual counseling Generic GROUP counseling Cognitive behavioral therapy (CBT) Motivational interviewing/enhancement therapy (MET) MET + CBT (MET/CBT) Psychoeducational therapy (PET) Contingency Management Vocational counseling Drug court
No Treatment
SLIDE 77 Results
Effect sizes were close and not statistically meaningful to make definitive statements about superiority…BUT
Family therapy & CBT/MET combo had stronger effects (on abstinence
- utcomes) than all compared treatment
conditions Individual counseling was less effective than all other treatment conditions with which it was compared
SLIDE 78 The Post-Treatm ent Period
In-Tx Factors In-Tx Factors
Recovery
SLIDE 79 Treatment Effectiveness Studies
Important to note: studies have NOT established a superior treatment approach
They all have equally effective results in terms of producing positive outcomes…
Reducing use Improving mental health/wellbeing, and Repairing social relations
Happy Ending?
SLIDE 80 Treatment Outcome Studies Treatment Outcome Studies
Although treatment is working…
Less than half of adolescents leave treatment with a positive discharge (still using) Relapse continues to be fairly common: ~65% relapse during first three months after tx completion (Brown et al., 1989) and longer-term (12 mos; Dennis et al.,2000) Lack of continuity of care: less than 10% participate in aftercare after formal tx
SLIDE 81 Been called many things Been called many things… …
Aftercare Continuing care Stepped-down care Extended interventions Disease management
McKay (2008)
SLIDE 82 Continuing Care Service Barriers
- Limited funding for services in the
addiction field
- Limited availability of services
- Hence, not a standard “clinical” practice
- Why pay when we have – 12 step model?
- Been referred to as “the perfect aftercare” (White,
2007)
SLIDE 83 Em pirical Support for CC
Evidence suggests clients who get continuing care have better outcomes than clients who do not receive CC services (McKay, 2009).
- Evidence mainly established for adults; less
clear for adolescents
- Very few continuing care studies of adolescents in
the scientific literature
- Godley et al. 2002 – home visits with youth after
residential tx (Assertive Continuing Care)
SLIDE 84
Brief Intervention
FLO
SLIDE 85 The 3 Tasks of a BI
Avoid Warnings!
F L O W
Feedback Listen & Understand Warn Options Explored
(that’s it)
85
SLIDE 86 How does it all fit together?
86
SLIDE 87 The 3 Tasks of a BI
F L O
Feedback Listen & Understand Options Explored
87
SLIDE 88 The First Task: Feedback
Your job in F is only to deliver the feedback! Let the consumer decide where to go with it. Ask for Permission explicitly
There’s something that concerns me. Would it be ok if I shared my concerns with you?
Provide direct feedback
The results of your screening form suggest that…
88
SLIDE 89 The First Task: Feedback
Handling resistance…
- Look, I don’t have a drug problem
- I just like to party with my friends
- I can quit using anytime I want to
- I just like the taste
- I’m young, what’s the big deal?
What would you say?
89
SLIDE 90 To avoid this…
LET GO!!!
The First Task: Feedback
90
SLIDE 91 The First Task: Feedback
Easy Ways to Let Go…
- I’m not going to push you to change anything you
don’t want to change…
- I’m not hear to convince you that you’re partying
too much…
- I’d just like to give you some information...
- I’d really like to hear your thoughts about…
- What you do is up to you….
91
SLIDE 92 Feedback: Content Areas for Adolescents
Alcohol Use Marijuana Use Prescription Medication Use Club drug use
92
Always ask this question: “What role, if any, do you think (substance) played in (problem) ?
SLIDE 93 The First Task: Feedback Let’s practice F: Role Play Giving Feedback ONLY
93
SLIDE 94 The 3 Tasks of a BI
F L O
Feedback Listen & Understand Options Explored
94
SLIDE 95 The Second Task: Listen and Understand
Listen for the change talk… Maybe drinking did play a role in what happened If I wasn’t partying, this would never have happened I don’t want to be in this mess again The last thing I want to do is hurt someone else I know I can quit because I’ve stopped before Summarize, so they hear it twice!
95
SLIDE 96 The Second Task: Listen and Understand
Dig for change talk…
- I’d like to hear your opinions about…
- What are some things that bother you about
your use?
- What role do you think drugs/alcohol played in
________________?
- How would you like your drinking to be 5 years
from now?
96
SLIDE 97 The Second Task: Listen and Understand
Tools for Change Talk
- Pros and Cons
- Importance & Confidence Scales
- Readiness Ruler
97
SLIDE 98 The Second Task: Listen and Understand
Strategies for weighing the pros and cons…
- “What do you like about drinking?”
- “What do you see as the downside of drinking?”
- “What Else?”
Summarize both pros and cons… “On the one hand you said.., and on the other you said….
98
SLIDE 99 The Second Task: Listen and Understand
Importance/Confidence/Readiness On a scale of 1–10…
- How important is it for you to change your drinking?
- How confident are you that you can change your
drinking?
- How ready are you to change your drinking?
For each ask…
- Why didn’t you give it a lower number?
- What would it take to raise that number?
1 2 3 4 5 6 7 8 9 10
99
SLIDE 100 The Second Task: Listen & Understand
Let’s practice L:
Role Play Listen & Understand Using Completed Screening Tools
- Pros and Cons
- Importance/Confidence/Readiness Scales
- Develop Discrepancy
- Dig for Change
- Create movement in Consumer’s Stage of
Readiness for Change
100
SLIDE 101 The 3 Tasks of a BI
F L O
Feedback Listen & Understand Options Explored
101
SLIDE 102 What now? What do you think you will do? What changes are you thinking about making? What do you see as your options? Where do we go from here? What happens next?
The Third Task: Options for Change
102
SLIDE 103 Offer a Menu of Options
- Manage drinking/use (cut down to low-risk limits)
- Eliminate your drinking/drug use (quit)
- Never drink and drive (reduce harm)
- Utterly nothing (no change)
- Seek help (refer to treatment)
- Set up appointment with prescribing physician
The Third Task: Options for Change
103
SLIDE 104 During MENUS You can also explore previous strengths, resources and successes
- “Have you stopped drinking/using drugs before?”
- “What personal strengths allowed you to do it?”
- “Who helped you and what did you do?”
- “Have you made other kinds of changes successfully in
the past?”
- “How did you accomplish these things?”
The Third Task: Options for Change
104
SLIDE 105 The Third Task: Options for Change
Giving Advice Without Telling Someone What to Do Ask for Permission explicitly There’s something that concerns me. Would it be ok if I shared my concerns with you? Preface advice with permission to disagree This may or may not be helpful to you
105
SLIDE 106 Putting it all together
Feedback Range Pros and Cons Importance/Confidence/Readiness Scales Summary Options Explored Listen and Understand Menu of Options
106
SLIDE 107 NIDA and SAMHSA Resources
“NIDA Red Book”
TIP 31: Screening & Assessing Adolescents for Substance Use Disorders TIP 32: Treatment of Adolescents With Substance Use Disorders For parents offer:
SLIDE 108 Contact Information Contact Information
Sherry Larkins larkins@ucla.edu
UCLAISAP www.uclaisap.org